Search

Your search keyword '"Metastasis -- Drug therapy"' showing total 1,668 results

Search Constraints

Start Over You searched for: Descriptor "Metastasis -- Drug therapy" Remove constraint Descriptor: "Metastasis -- Drug therapy" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
1,668 results on '"Metastasis -- Drug therapy"'

Search Results

1. Its time to take a different a targeted therapy:direction with: THE AND APPROVED SECOND-LINE (2L) ORAL to treat locally advanced or metastatic urothelial carcinoma expressing FGFR3 alterations/mutations that has progressed on or after at least one line of prior systemic therapy (1) Set a new direction with your 2L treatment decision (1)

2. SEC recommends approval of additional indication for BMS' anti-cancer drug nivolumab

3. SEC recommends approval of additional indication for BMS' anti-cancer drug nivolumab

4. Data from Hamilton Health Sciences Broaden Understanding of Carcinomas (Efficacy and Safety of Lenvatinib in Combination With Other Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma)

5. AstraZeneca, Daiichi Sankyo seek US FDA's accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC

6. Ministry of Health of Russia Researchers Update Current Data on Thyroid Cancer (Observation and treatment of patients with progressive metastatic differentiated thyroid cancer after establishment of radioiodine refractoriness)

7. Department of Internal Medicine Researcher Targets Liver Cancer (Metastasis to the skull base involving the sphenoid and cavernous sinus in hepatocellular carcinoma)

8. Data from Shanghai Jiao Tong University School of Medicine Update Knowledge in Lung Cancer [Evaluation of the prognostic value of the new 9th edition Tumor-Node-Metastases (TNM) staging system for epidermal growth factor receptor (EGFR)-mutated ...]

9. Data on Non-Small Cell Lung Cancer Described by Researchers at Jiangsu University (Immune Checkpoint Inhibitors With or Without Radiotherapy In Metastatic Non-small Cell Lung Cancer: a Meta-analysis and Literature Review)

10. FDA approves Roche's inavolisib combo for metastatic breast cancer

11. Theriva achieves target patient enrollment in VIRAGE phase 2b trial of VCN-01 with gemcitabine/nab-paclitaxel to treat metastatic pancreatic cancer

12. Studies from University of Ulsan College of Medicine Provide New Data on Breast Cancer (Longitudinal dynamics of circulating tumor DNA for treatment monitoring in patients with breast cancer recurrence)

13. Investigators from Shenyang University of Chemical Technology Have Reported New Data on Drug Research (Design, Synthesis and Pharmacological Evaluation of Novel 4-phenoxyquinoline Derivatives As Vegfr2 Kinase Inhibitors for Tumor Treatment)

14. Merck gets US FDA approval for Keytruda plus pemetrexed & platinum chemotherapy to treat unresectable advanced or metastatic MPM

15. Researcher at University Hospital Ulm Details Research in Breast Cancer (Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability - Real-World Data from ...)

16. U.S. FDA OKs FoundationOneCDx and FoundationOneLiquid CDx as Companion Diagnostics for Lynparza (olaparib) in Combination with Abiraterone for Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

18. Data from Zhengzhou University Provide New Insights into Squamous Cell Carcinoma (Luteolin Enhances Drug Chemosensitivity By Downregulating the Fak/pi3k/akt Pathway In Paclitaxel-resistant Esophageal Squamous Cell Carcinoma)

19. Studies from Stanford Medicine Provide New Data on Breast Cancer (Durable Responses To Trastuzumab Deruxtecan In Patients With Leptomeningeal Metastases From Breast Cancer With Variable Her2 Expression)

20. Studies from Astellas Pharma Inc. Add New Findings in the Area of Urothelial Cancer (Population Pharmacokinetic Modeling and Exposure-response Analysis for the Antibody-drug Conjugate Enfortumab Vedotin In Locally Advanced or Metastatic ...)

21. Drug-chemo combo increases cancer treatment efficacy

22. New Breast Cancer Findings from Sichuan University Outlined (Dual-responsive Shape-transformable Charge-reversible Nanoparticles Combined With Chemo-photodynamic-immunotherapy for the Treatment of Breast Cancer and Lung Metastasis)

23. 'Target-and-release' nanoparticles for effective immunotherapy of metastatic ovarian cancer

24. Reports from University of Rochester Medical Center Advance Knowledge in Health and Medicine (Hyaluronidase inhibitor delphinidin inhibits cancer metastasis)

25. Investigators from Institute for Molecular Medicine Have Reported New Data on Cancer (Membrane Lipid Replacement for Reconstituting Mitochondrial Function and Moderating Cancer-related Fatigue, Pain and Other Symptoms While Counteracting the ...)

26. U.S. FDA OKs FoundationOneLiquid CDx as a Companion Diagnostic for AKEEGA (niraparib and abiraterone acetate) for Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer

27. Tiragolumab Combo Misses Endpoints in Metastatic Non-Squamous NSCLC Trial

28. Reports on Carcinomas from University of Science and Technology China Provide New Insights (Successful Treatment of Trichilemmal Carcinoma With Distant Metastasis Using Pembrolizumab: a Case Report and Review)

29. Oncoinvent Gets FDA Fast Track Designation for Radspherin as Treatment for Peritoneal Carcinomatosis from Ovarian Cancer

30. Oncoinvent receives US FDA fast track designation for Radspherin to treat patients with peritoneal metastases from ovarian cancer

31. Investigators from Weill Cornell Medicine Target Cancer [Characterizing 'collateral Damage' In Men and Women With Metastatic Breast Cancer (Mbc) From Diverse Racial and Ethnic Backgrounds In New York City]

32. University of Manchester Researchers Illuminate Research in Prostate Cancer (Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid review)

33. Researchers from King Abdulaziz University Detail Research in Cancer (Diagnosis, investigation, and treatment of occult breast cancer: A case report and systematic review of the literature)

34. UPDATES ON ADVANCED BLADDER CANCER TREATMENT

36. Erdafitinib in the Treatment of Metastatic Urothelial Carcinoma

37. Retevmo Approved for Younger Patients With RET-Driven Thyroid Cancer, Solid Tumors

38. Genmab-Pfizer's gains full FDA approval for TIVDAK in Metastatic Cervical Cancer

39. Genmab-Pfizer gain full FDA approval for TIVDAK in Metastatic Cervical Cancer

40. Reports Outline Prostate Cancer Study Findings from Memorial Sloan-Kettering Cancer Center (Phase I Study of Oric-101, a Glucocorticoid Receptor Antagonist, In Combination With Enzalutamide In Patients With Metastatic Castration-resistant ...)

41. Investigators from Shandong Cancer Hospital and Institute Report New Data on Gastric Cancer (Efficacy and Safety of Sintilimab Combined With Apatinib As Third-line or Above Therapy for Patients With Advanced or Metastatic Gastric Cancer)

42. Dokuz Eylul University Researchers Further Understanding of Colon Cancer (In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens)

43. Studies from Hull York School of Medicine Have Provided New Information about Cancer (trans-iv Restriction: a New Configuration for Metal Bis-cyclam Complexes As Potent Cxcr4 Inhibitors)

44. SEC recommends approval to Dr Reddy's to import and market anti-cancer drug toripalimab

45. SEC recommends approval to Dr Reddy's to import and market anti-cancer drug toripalimab

46. Zhejiang Cancer Hospital Researcher Highlights Research in Immunotherapy (Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory ...)

47. Studies from Weill Cornell Medicine Further Understanding of Prostate Cancer (Abstract 1231: First-in-class AR-V7/AR-fl small molecule molecular glue degrader for prostate cancer treatment)

48. Shanghai Jiao Tong University School of Medicine Researchers Update Knowledge of Breast Cancer (LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1a signaling)

49. New Findings from Rush University Medical Center Describe Advances in Prostate Cancer (Effect of Concomitant Medications On Treatment Response and Survival In De Novo Metastatic Prostate Cancer: Secondary Analysis of the Latitude Study)

50. Studies from Shanghai Jiao Tong University School of Medicine Provide New Data on Ovarian Cancer (Study on the diagnostic efficacy of ADNEX model in differentiating metastatic and primary ovarian cancer)

Catalog

Books, media, physical & digital resources